학술논문
Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study.
Document Type
Report
Author
Thomas E; Protherics Medicines Development Ltd, Blaenwaun, UK emma.thomas@btgsp.com.; Tomlinson S; Protherics UK Ltd, London, UK.; Thomas S; Protherics UK Ltd, London, UK.; Ward S; BTG International Inc, Conshohocken, Pennsylvania, USA.; Daugherty C; BTG International Inc, Conshohocken, Pennsylvania, USA.; Gallardo E; Protherics Medicines Development Ltd, Blaenwaun, UK.; Hill C; BTG International Inc, Conshohocken, Pennsylvania, USA.
Source
Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2047-9956 (Print) Linking ISSN: 20479956 NLM ISO Abbreviation: Eur J Hosp Pharm Subsets: MEDLINE
Subject
Language
English
ISSN
2047-9956
Abstract
Competing Interests: Competing interests: ET and EG are employees of Protherics Medicines Development Ltd. STo was an employee of Protherics UK Ltd at the time these analyses were performed. STh is an employee of Protherics UK Ltd. SW, CD and CH are employees of BTG International Inc.